Prevalence and risk factors for hepatitis c and human immunodeficiency virus coinfection among children in Enugu Nigeria

African Journal of Infectious Diseases

Volumn 8, Issue 1, 2014, Pages 5-8

  Eze, Jude Chijioke ^a   Ibeziako, Ngozi S ^b   Ikefuna, Anthony N ^b   Nwokoye, Ikenna C ^c   Uleanya, Nwachinaemere D ^c   Ilechukwu , Gideon C ^d  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b UNTH   (Nigeria)

^c UNIVERSITY OF NIGERIA   (Nigeria)

^d WHISTON HOSPITAL   (United Kingdom)

Author keywords

Co infection; Hepatitis C; Human immunodeficiency virus

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; CHILD; CHROMATOGRAPHY; COMPUTER PROGRAM; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INJECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NIGERIA; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SCHOOL CHILD; VIRUS DETECTION;

EID: 84887482795     PISSN: 20060165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Alter MJ (2007). Epidemiology of viral hepatitis. World J Gastroenterol., 13: 2436-41.
2. Agbede OO, Iseniyi JO, Kolawole OM, Ojuawo A. (2006). Risk factors and seroprevalence of hepatitis C antibodies in mothers and their pre-school age children in Ilorin. Afri J Clin Exper Microbiol 2006;7:153-57.
3. Agwale SM, Tanimoto L, Womack C, Oduma L, Lueng K. (2004). Prevalence of hepatitis C co-infection in HIV infected individuals in Nigeria and characterization of genotypes. J Clin Virol., 5:53-56.
4. Armstrong GL, Wasley A, Simard EP, Mc Quillan GM, Kuhnart WL, Alter MJ (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med., 144: 705-14.
5. Esteban JI, López-Talavera JC, Genescà J, Madoz P, Viladomiu L, Muñiz E, Martin-Vega C, Rosell M, Allende H, Vidal X, González A, Hernández JM, Esteban R, Guardia J (1999). High rate of infectivity and liver disease in blood donors with antibodies to Hepatitis C Virus. Ann Intern Med.,115: 443-49.
6. Hauri A, Armstrong G, Hutin Y. (2004). The global burden of disease attributable to contaminated injections given in healthcare settings. Inj J STD and AIDS, 15:7-16.
7. Hoofnagle JH. Hepatitis C. (1997).The clinical spectrum of disease. Hepatology, 26:15s-20s.
8. Inyama PU, Uneke CJ, Anyanwu GI, Njoku OM, Idoko JH, Idoko JA (2005). Prevalence of antibodies to hepatitis C virus among Nigeria patients with HIV infection. Online J Health All Sci 2005 @ www.ojhas.org/issue4/2005-2-2htm.
9. Lesi OA, Kehinde MO, Ogah DN, Amira CO (2007). Hepatitis B and C virus in Nigerian patients with HIV/AIDS. Nig Post Grad Med infection J, 14:129-33.
10. Madhara V, Burgess C, Prucker E (2002). Epidemiology of chronic hepatitis C infection in Sub-Saharan Africa. Lancet, 2157: 293-302.
11. Mboto I, Davis A, Fielder M, Jewel AP (2006). Human Immunodeficiency virus and hepatitis C co-infection in Sub-Sahara West Africa. Br J Biomed Sci., 63:29-37.
12. Menendez C, Sanchez-Tapias JM, Kahigwa E, Mshinda H, Costa J, Vidal J, Acosta C, Lopez-Labrador X, Olmedo E, Navia M, Tanner M, Rodes J, Alonso PL (1999). Prevalence and mother to infant transmission of hepatitis viruses B,C and E in Southern Tanzania. J Med Virol.,58:215-220.
13. NIH (2002). NIH Management of hepatitis C: 2002 NIH concens state sci statements 2002;19:1-46.
14. Oni AD, Harrison TJ (1996). Genotype of hepatitis C in Nigeria. J Med Virol., 49:178-86.
15. Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P (2008). Prevalence of Hepatitis B and C seropositivity in a Nigerian cohort of HIV infection. Ann Hepatol.,7:152-56.
16. Sulkwoski MS (2008). Viral hepatitis and HIV co-infection. J Hepatol.,48:353-67.
17. Telatela PS, Matee MI, Munubhi EK. (2007). Seroprevalance of hepatitis B and C viral co infections among children co-infected with Human Immunodeficiency Virus attending the paediatric HIV care and treatment centre at Muhimbili National Hospital in Dar-es-salaam, Tanzania, BMC Public Health. 2007;7:338 @ http// www.biomedcentral.com.
18. Vallet-Richard A, Pol S. (2006). Natural history and predictors of severity of chronic hepatitis C virus and HIV co-infection. J Hepatol., 44:528-34.
19. WHO (2000).WHO: Hepatitis C fact sheet; No 164, revised Oct. 2000 https://apps.who.int/inf-fs/en/fact164.html
20. WHO/UNAIDS (2009). Epidemic Update @ http//www.unaids.org/epi update 2009